CANCER SURVIVORSHIP AND EXERCISE ONCOLOGY
Professor Sandra Hayes, Director of Research
Cancer Council Queensland (CCQ), Brisbane, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | April 2025
Professor Sandra Hayes is the Director of Research at Cancer Council Queensland (CCQ), where she leads a comprehensive cancer research program encompassing cancer epidemiology, prevention, detection, treatment, and survivorship.
With a BAppSci (Hons) and a PhD in exercise oncology, Professor Hayes’s expertise lies in quantifying the impact of cancer diagnosis and treatment on physical and psychosocial wellbeing, quality of life, and survival. She also evaluates innovative supportive care strategies, particularly exercise, to improve post-cancer lives.
Professor Hayes has authored 170 peer-reviewed publications, been a Chief Investigator on grants totalling more than AUD$20M, leading world-renowned randomised trials and longitudinal oncology cohort studies involving over 9000 participants across more than 10 cancer sites. Recognised internationally as an expert in exercise oncology, Professor Hayes has held executive positions on national and international committees, including the Clinical Oncology Society of Australia and the International Society of Lymphology.
Her research has been funded by several organisations over the past 25 years, including government funding support through National Health and Medical Research Council grants and more recently the Medical Research Future Fund. Professor Hayes has also been supported from funding from organisations such as the National Breast Cancer Foundation and Cancer Council Queensland, as well as international funding from the World Cancer Research Fund.
Her professional activities include peer review for top oncology and exercise science journals and advisory roles for various cancer and exercise organisations. Her research impact includes leading national and international position statements on exercise for cancer patients, co-developing the Clinical Oncology Society of Australia’s physical activity guidelines, and creating resources for the International Exercise is Medicine® campaign.
She has also developed the YWCA Encore breast cancer rehabilitation program and lymphoedema diagnostic criteria used globally.
Source: Supplied
https://orcid.org/0000-0002-7005-5184
-
Risk factors and prevention of respiratory infections and infectious diseases in children
A/Prof Hannah Moore OAM is an infectious disease epidemiologist; Co-Head of the Infectious Disease Epidemiology team within the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia and Associate Professor at the School of Population Health, Curtin University in Western Australia.
A/Prof Moore has been awarded more than $19M in competitive research grants, co-authored more than 140 papers, was TEDxPerth 2018 speaker, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 2024, she was honoured with a Medal of the Order of Australia for her service to epidemiology as a researcher.
-
Role of Community Paramedicine in Non-Emergency Presentations
Dr Robbie King is a Lecturer in paramedicine and researcher at the Australian Catholic University (ACU) Brisbane. He also continues to provide clinical care as a registered paramedic for community members served by a jurisdictional ambulance service. Dr King has gained significant experience working in an advanced practice, community paramedic style role, holding expert clinical insight into the nuances of paramedic-led community-based healthcare for non-emergency presentations. This often involves adopting a biopsychosocial approach, rather than following the biomedical model more associated with emergency medicine and paramedic culture.
-
Causal genes and pathogenic mechanisms underlying gastrointestinal diseases
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
